Table 2. Summary of Clinic Blood Pressure and AMBP at Baseline, 6-Month, and 12-Month Visits.
Visit | Participants, No. | Mean (SD) | |||
---|---|---|---|---|---|
Measured BP, mm Hga | Change from baselineb | ||||
Systolic | Diastolic | Systolic | Diastolic | ||
AMBP | |||||
Baseline | |||||
Control | 159 | 133.01 (12.67) | 87.04 (8.16) | [Reference] | [Reference] |
Intervention | 157 | 132.59 (14.27) | 86.45 (7.76) | [Reference] | [Reference] |
6-mo | |||||
Control | 102 | 130.69 (13.99) | 85.89 (9.19) | −2.20 (10.72)c | −0.74 (7.86)d |
Intervention | 100 | 128.14 (11.36) | 84.61 (8.24) | −4.19 (9.77)e | −2.17 (7.04)f |
P value | NA | .12 | .16 | NA | NA |
12-mo | |||||
Control | 88 | 129.47 (14.71) | 85.52 (9.43) | −2.23 (13.82)d | −0.36 (8.94)d |
Intervention | 85 | 128.54 (11.95) | 85.34 (9.32) | −3.21 (10.72)f | −1.14 (8.52)d |
ANCOVA P value | .59 | .58 | NA | NA | |
Clinic | |||||
Baseline | |||||
Control | 159 | 137.97 (14.33) | 91.77 (11.26) | [Reference] | [Reference] |
Intervention | 157 | 138.30 (14.27) | 90.81 (11.42) | [Reference] | [Reference] |
6-mo | |||||
Control | 104 | 132.50 (15.83) | 86.70 (12.44) | −5.59 (14.29)e | −4.86 (9.79)e |
Intervention | 100 | 130.84 (12.16) | 83.83 (9.36) | −6.62 (12.52)e | −5.70 (9.87)e |
ANCOVA P value | NA | .41 | .20 | NA | NA |
12-mo | |||||
Control | 90 | 130.7 (15.22) | 85.15 (12.31) | −6.41 (14.67)e | −5.56 (12.22)e |
Intervention | 86 | 131.16 (12.77) | 85.05 (10.56) | −5.78 (13.53)e | −4.29 (10.31)e |
ANCOVA P value | NA | .78 | .69 | NA | NA |
Abbreviations: AMBP, ambulatory BP; ANCOVA, analysis of covariance; BP, blood pressure; NA, not applicable.
ANCOVA test was used to compare measured BP at each point between study groups.
Paired t test was used to compare changes from baseline in BP within each study group.
P ≤ .05.
Not significant.
P ≤ .01.
P ≤ .001.